Efficacy of an internal teat sealant alone or in combination with an intramammary antibiotic during the dry period treatment in dairy cows

Abstract

In this study, the aim was to determine the effectiveness of internal teat sealant applied at the dry-off in preventing the formation of subclinical mastitis and to investigate whether this product could be a non-antibiotic alternative to total dry cow treatment. A total of 195 quarters from 52 Holstein and Holstein Crossbreed dairy cows, that did not have clinical mammary infection and were expected to calve within 60 days were used in the study. The quarters were divided into 3 treatment groups as follows: Group 1 (ANTB; n = 64): dry period intramammary antibiotic suspension (Ubrostar®); Group 2 (ORB; n = 65), internal teat sealant (Orbeseal®); and Group 3 (ANTB-ORB; n = 66) intramammary antibiotic and teat sealant combination were performed. All of the quarters were checked for subclinical mastitis on the 20th, 40th and 60th days of lactation. The percentage of animals found to be CMT negative on the 20th day of lactation was 80.65% in G1 (ANTB), 83.60% in Group 2 (ORB), and 87.50% in Group 3 (ANTB-ORB), respectively. There was no quarter with CMT +3 score in G1 and G3, but it was determined in one quarter in G2 (ORB). On the 60th day there were no quarters with CMT +2 and +3 scores in both G1 and G2. No statistically significant difference was found between the CMT results of treatment groups on the 20th, 40th and 60th days of lactation (p > 0.05). In conclusion, it was determined that bismuth subnitrate-based teat canal sealer provided good protection against subclinical mastitis rate in drying healthy udder quarters. However, especially in high risk groups it is important to closely monitor udder health with SCC and/or CMT applications before the dry period and to choose the dry period treatment.